Table 3.
Cu/ Zn Ratio in All Study Groups
| Tumor Type | Cu/Zn |
|---|---|
| Benign: PA (16) | 1.03±0.3 |
| Malignant: MEC (18) | 1.5±1. 8 |
| ADCC (10) | 1 ±0.4 |
| ACC (4) | 1.1±0.4 |
| SCC (4) | 1.03±0.6 |
| Malignant mixed tumor (8) | 0.8 ±0.4 |
| Control (28)- | 1.1±0.3 |
PA, pleomorphic adenoma; MEC, mucoepidermoid carcinoma; ADCC, adenoid cystic carcinoma; ACC, acinic cell carcinoma; SCC, Squamous cell carcinoma